Myasthenia Gravis: Reflections on Past Challenges and Evolving StrategiesFebruary 28, 2024Myasthenia Gravis
Myasthenia Gravis: Lessons on a Comprehensive Approach to Patient CareFebruary 28, 2024Myasthenia Gravis
Myasthenia Gravis: A Mentor's Emphasis on Patient-Centered OutcomesFebruary 28, 2024Myasthenia Gravis
Neurology ReviewsAutoimmune Disease Risk May Rise Following Cushing Disease Remission After SurgeryFebruary 22, 2024Multiple SclerosisMyasthenia GravisNeurosurgery & Trauma
Neurology ReviewsNovel myasthenia gravis therapies bring opportunities, challengesNovember 21, 2023Myasthenia GravisRare DiseasesNeuromuscular Disorders
Neurology ReviewsNewly approved myasthenia gravis drug shows sustained benefits in early respondersNovember 15, 2023Myasthenia GravisRare DiseasesNeuromuscular Disorders
Neurology ReviewsU.S. study finds unexpectedly high prevalence of myasthenia gravisNovember 8, 2023Myasthenia GravisNeuromuscular DisordersRare Diseases
Neurology ReviewsIn myasthenia gravis, antibodies pass open-label testsNovember 3, 2023Myasthenia GravisNeuromuscular DisordersRare DiseasesPediatrics
Neurology ReviewsMyasthenia gravis drug gets FDA nodJune 27, 2023Myasthenia GravisRare DiseasesNeuromuscular Disorders
Neurology ReviewsU.S. incidence, prevalence of myasthenia gravis is risingMay 3, 2023Myasthenia GravisRare DiseasesNeuromuscular Disorders
Neurology ReviewsMyasthenia gravis: Finding strength in treatment optionsOctober 15, 2022Myasthenia GravisRare DiseasesMixed Topics
